IDIOPATHIC CD4 LYMPHOPENIA
Clinical trials for IDIOPATHIC CD4 LYMPHOPENIA explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC CD4 LYMPHOPENIA trials appear
Sign up with your email to follow new studies for IDIOPATHIC CD4 LYMPHOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lupus drug help people with rare immune deficiency?
Disease control Recruiting nowThis early-stage study tests whether belimumab, a drug used for lupus, is safe for people with idiopathic CD4 lymphopenia (ICL) — a rare condition where the body has too few CD4 immune cells, raising infection risk. About 20 adults aged 18-70 with ICL and autoantibodies will rece…
Matched conditions: IDIOPATHIC CD4 LYMPHOPENIA
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Experimental drug aims to rebuild immune defenses in rare disease
Disease control Recruiting nowThis study tests a new drug called NT-I7 in people with idiopathic CD4 lymphopenia (ICL), a rare condition where the body lacks key immune cells called CD4 T cells. The goal is to see if NT-I7 can safely increase these cells and help prevent severe infections. About 60 adults age…
Matched conditions: IDIOPATHIC CD4 LYMPHOPENIA
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 07, 2026 18:43 UTC